Noreen Henig
CIK 1810995 · Chief Medical Officer · last filed 2026-02-27
Noreen Henig is a Chief Medical Officer who has filed 11 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing, for RNAM, was dated Feb 27, 2026. Current disclosed insider exposure totals $82.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$82.8K
3
11
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Avidity Biosciences, Inc. (RNAM) Delisted | Director | 0 | — | — | $0 | 1 | 2026-02-27 |
| RNA | Director | 6,692 | $12.37 | $82.8K | $0 | 5 | 2025-06-12 |
| Kezar Life Sciences, Inc. (KZR) Delisted | Chief Medical Officer | — | $7.29 | — | $0 | 5 | 2023-07-26 |
Recent Filings
11 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-27 | Avidity Biosciences, Inc. (RNAM) Delisted | Disp (D) | −6,692 | $0 | EDGAR |
| 2025-06-12 | RNA | Grant (A) | +6,692 | $0 | EDGAR |
| 2024-06-14 | RNA | Grant (A) | — | $0 | EDGAR |
| 2023-07-26 | Kezar Life Sciences, Inc. (KZR) Delisted | Mixed | — | $0 | EDGAR |
| 2023-06-20 | RNA | Grant (A) | — | $0 | EDGAR |
| 2023-01-10 | Kezar Life Sciences, Inc. (KZR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-17 | RNA | Grant (A) | — | $0 | EDGAR |
| 2022-01-07 | Kezar Life Sciences, Inc. (KZR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-16 | RNA | Grant (A) | — | $0 | EDGAR |
| 2021-01-11 | Kezar Life Sciences, Inc. (KZR) Delisted | Grant (A) | — | $0 | EDGAR |